Dixon Hubard Feinour & Brown’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Dixon Hubard Feinour & Brown's HALO Position: Q2 2022 in Review
Dixon Hubard Feinour & Brown held its Halozyme (HALO) position steady in Q2 2022 at 20,218 shares worth $890K. The position accounts for 0.11% of the portfolio, ranked #153.
Dixon Hubard Feinour & Brown first reported a position in HALO in Q3 2016 and has held it in 24 quarters since. The position peaked at $949K in Q1 2021. 367 funds tracked by Wall St. Rank hold HALO as of Q2 2022.
- Dixon Hubard Feinour & Brown held 20,218 shares of Halozyme worth $890K as of Q2 2022.
- Dixon Hubard Feinour & Brown left its Halozyme share count unchanged in Q2 2022.
- Halozyme made up 0.11% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #153 holding.
- Dixon Hubard Feinour & Brown first reported a position in Halozyme in Q3 2016 and has held it in 24 quarters since.
- Dixon Hubard Feinour & Brown's Halozyme position peaked at $949K in Q1 2021.
- 367 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.